US Equities Analysis

DVA — DaVita

DVA DVA Price Chart

DaVita (DVA) is a health care services company in the Health Care sector. Listed on the NASDAQ, DaVita is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $198.54.

Key Metrics & Risk

Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).

MetricValue
Latest Price$198.54
Latest Date2026-06-10
Expected Return (Annualized)16.80%
Risk / Std Dev (Annualized)37.29%
Sharpe Ratio (rf=4.5%)0.33

S&P 500 Context

  • Sector: Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Index: S&P 500 Component

Risk/Return Profile

The stock shows an annualized expected return of 16.80% with an annualized volatility of 37.29%. The Sharpe ratio of 0.33 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.

Modern Portfolio Theory Positioning

This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.

Fundamentals

MetricValue
Market Cap12.74B
Enterprise Value27.1B
Trailing P/E19.13
Forward P/E11.56
Price to Book-17.39
Price to Sales0.92
EV/Revenue1.96
EV/EBITDA9.71

| Profitability | | | Profit Margin | 5.65% | | Operating Margin | 13.86% | | ROE | 80.98% | | ROA | 7.5% |

| Growth | | | Revenue Growth | 6.0% | | Earnings Growth | 43.5% |

| Financial Health | | | Total Revenue | 13.84B | | Total Debt | 13.22B | | Total Cash | 0.67B | | Free Cash Flow | 1.0B | | Operating Cash Flow | 2.03B |

| Price & Technical | | | 52W High | $202.69$ | | 52W Low | $101.0$ | | 50-Day Avg | $172.35$ | | 200-Day Avg | $139.91$ | | Beta | 0.91 | | Shares Outstanding | 0.06B | | Float Shares | 0.03B | | Insider Holdings | 50.3% | | Institutional Holdings | 52.63% | | Short Ratio | 4.6 | | Short % of Float | 14.79% |

| Analyst Targets | | | Target High | $235.0$ | | Target Low | $145.0$ | | Target Mean | $193.71$ | | Target Median | $201.0$ | | # of Analysts | 7 | | Recommendation | none |

Disclaimer

This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.

us-equity stock equity dva health-care health-care-services nasdaq